▶ 調査レポート

自動輸血システムの世界市場:成長・動向・市場規模予測(2020-2025)

• 英文タイトル:Auto-transfusion Systems Market - Growth, Trends, and Forecast (2020 – 2025)

Mordor Intelligenceが調査・発行した産業分析レポートです。自動輸血システムの世界市場:成長・動向・市場規模予測(2020-2025) / Auto-transfusion Systems Market - Growth, Trends, and Forecast (2020 – 2025) / D0-MOR-AP0136資料のイメージです。• レポートコード:D0-MOR-AP0136
• 出版社/出版日:Mordor Intelligence / 2020年4月20日
• レポート形態:英文、PDF、100ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:健康管理
• 販売価格(消費税別)
  Single User¥454,750 (USD4,250)▷ お問い合わせ
  Team User¥508,250 (USD4,750)▷ お問い合わせ
  Corporate License¥802,500 (USD7,500)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートは、自動輸血システムの世界市場について調査・分析した資料で、自動輸血システムの市場概要、動向、セグメント別市場規模、地域別分析、競争状況、企業情報、市場機会分析などで構成されています。

The Auto-transfusion Systems market studied was projected to grow with a CAGR of 5.2% over the forecast period. The major factor attributing to the growth of the market is the increase in the number of surgical procedures which can be attributed to the increase in the prevalence of chronic disease and increasing prevalence of lifestyle diseases, due to sedentary living. Furthermore, the scarcity of donated blood or allogeneic blood is also boosting the growth of the market. According to NPR.org in India, across all 107 countries with an insufficient supply of blood, the shortfall counted up to 100 million units of blood. Of those, 41 million were needed in India. However, the high cost of the auto-transfusion devices and the risk associated with the procedure constraints the market growth.
Key Market Trends

Cardiac Surgeries Segment is Dominating the Auto-transfusion Systems Market.

The largest share of the segment can be attributed to the increasing prevalence of cardiac diseases and recommendations for autologous transfusion in cardiac surgeries. According to World Health Organisation, cardiovascular diseases are the number one cause of death globally, taking an estimated 17.9 million lives every year. According to American heart Association, about 2,300 Americans die of cardiovascular disease each day, an average of 1 death every 38 seconds, about 92.1 million American adults are living with some form of cardiovascular disease or the after-effects of stroke. Furthermore, the growth of the segment is also increased due to the increasing inadequacy of donated blood or allogenic blood.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall market, throughout the forecast period. The market growth is due to factors such as the presence of key players, a high number of surgeries the region, established healthcare infrastructure are some of the key factors accountable for its large share in the market. Furthermore, beneficial government initiatives and awareness of auto-transfusion due to lack of allogenic blood in the region are some of the drivers expected to increase the market growth. In this region, the United States has the maximum share due to supportive healthcare policies, and a developed healthcare market. According to the American National Red Cross, approximately 36,000 units of red blood cells are needed every day in the United States. As per the statistics, the increasing deficit of the donated blood and increasing disposable revenue in this country boosts the market growth of the region.

Competitive Landscape

The Auto-transfusion Systems market is moderately competitive and consists of several major players. Some of the companies which are currently dominating the market are Becton, Dickinson and Company, Beijing ZKSK Technology Co., Ltd., Braile Biomédica, Haemonetics Corporation, LivaNova PLC, Medtronic, Redax, Teleflex Incorporated, Zimmer Biomet.

Reasons to Purchase this report:

– The market estimate (ME) sheet in Excel format
– 3 months of analyst support

レポート目次

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Number of Surgical Procedures
4.2.2 Scarcity of Donated Blood/Allogenic Blood
4.3 Market Restraints
4.3.1 High Costs Associated With Autotransfusion Systems
4.3.2 Risks Associated With Autotransfusion
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Devices
5.1.2 Consumables
5.2 By Application
5.2.1 Cardiac Surgeries
5.2.2 Orthopedic Surgeries
5.2.3 Organ Transplantation
5.2.4 Others
5.3 By End-User
5.3.1 Hospitals
5.3.2 Ambulatory Surgical Centers
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Becton, Dickinson and Company
6.1.2 Beijing ZKSK Technology Co., Ltd.
6.1.3 Braile Biomedica
6.1.4 Zimmer Biomet
6.1.5 Medtronic Plc
6.1.6 LivaNova PLC
6.1.7 Redax Spa
6.1.8 Gen World Medical Devices
6.1.9 Haemonetics Corporation
6.1.10 Teleflex Incorporated

7 MARKET OPPORTUNITIES AND FUTURE TRENDS